Cameroon vs Chad: Hepatitis B surface antigen (HBsAg) prevalence
Cameroon
1.8%
in 2024
Chad
2.2%
in 2024
Cameroon rank
13th
Chad rank
11th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cameroon
- Chad
How they compare
Chad currently reports 2.2% against 1.8% in Cameroon, a difference of 0.4%.
That makes Chad's figure about 1.2 times Cameroon's.
Across all 10 years both countries report, Chad has been ahead every year.
Cameroon ranks 13th and Chad ranks 11th of 194 countries.
Chad has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 4.1% | 2.1% | Chad |
| 2020s | 2.0% | 3.0% | 1.0% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cameroon or Chad?
- Chad, at 2.2% against 1.8% in Cameroon as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cameroon and Chad?
- 0.4%, with Chad ahead.
- How many years of comparable data are there for Cameroon and Chad?
- 10 years are reported by both, from 2015 to 2024.
- How do Cameroon and Chad rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cameroon ranks 13th and Chad ranks 11th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.